<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03508102</url>
  </required_header>
  <id_info>
    <org_study_id>2015001</org_study_id>
    <nct_id>NCT03508102</nct_id>
  </id_info>
  <brief_title>Effect of Remifentanil on the Bispectral Index in Women Undergoing Caesarean Delivery Under General Anaesthesia</brief_title>
  <official_title>Effect of Remifentanil on the Bispectral Index in Women Undergoing Caesarean Delivery Under General Anaesthesia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>West China Second University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>West China Second University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients undergoing caesarean delivery under inhalation anaesthesia are at a high risk of
      awareness, especially in the period before delivery. The investgators assessed the effects of
      remifentanil on the bispectral index (BIS) in the interval before delivery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sixty primipara undergoing elective cesarean delivery were randomly assigned to receive
      remifentanil 1 μg kg-1 (R1) or 0.5 μg kg-1 (R0.5), or saline (control) over 15 s with
      induction of anesthesia using propofol 2 mg kg-1 and suxamethonium 1.5 mg kg-1.The
      investgators assessed the average value of BIS at the time period of before, induction ,
      intubation, skin incision, peritoneum incision , uterine incision , and delivery. The
      investgators also determined the neonatal Apgar scores, and conducted umbilical artery blood
      gas analysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2015</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the effects of remifentanil on the bispectral index (BIS) in the interval before delivery.</measure>
    <time_frame>the time of before induction, induction , intubation, skin incision, peritoneum incision , uterine incision , and delivery</time_frame>
    <description>the average value of BIS at the time period of before induction, induction , intubation, skin incision, peritoneum incision , uterine incision , and delivery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>incidence of intraoperative awareness</measure>
    <time_frame>one day and one week after delivery.</time_frame>
    <description>the maternal incidence of intraoperative awareness</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Intraoperative Awareness</condition>
  <arm_group>
    <arm_group_label>Remifentanil 1 μg kg-1 (R1)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Received remifentanil 1μg/kg when induction of general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Remifentanil 0.5 μg kg-1 (R0.5),</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Received remifentanil 0.5μg/kg when induction of general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>saline (control)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Injected the equal volume normal saline when induction of general anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>remifentanil</intervention_name>
    <description>the effects of remifentanil on the average value of BIS at the time period of before induction , induction , intubation , skin incision, peritoneum incision, uterine incision, and delivery</description>
    <arm_group_label>Remifentanil 1 μg kg-1 (R1)</arm_group_label>
    <arm_group_label>Remifentanil 0.5 μg kg-1 (R0.5),</arm_group_label>
    <other_name>saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA physical status I or II who elected to undergo Caesarean section, under general
             anaesthesia

        Exclusion Criteria:

          -  multiple fetuses,preterm delivery, known fetal anomalies, pregnancy-induced
             hypertension, or any other medical complication
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 29, 2017</study_first_submitted>
  <study_first_submitted_qc>April 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2018</study_first_posted>
  <last_update_submitted>April 15, 2018</last_update_submitted>
  <last_update_submitted_qc>April 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>West China Second University Hospital</investigator_affiliation>
    <investigator_full_name>Qing Zhu</investigator_full_name>
    <investigator_title>attending physician</investigator_title>
  </responsible_party>
  <keyword>remifentanil</keyword>
  <keyword>bispectral index</keyword>
  <keyword>Caesarean delivery</keyword>
  <keyword>general anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intraoperative Awareness</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Remifentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

